Age-dependent sympathetic neural responses to Β-1 selective beta-blockade in untreated hypertension-related tachycardia.

about

Age-dependent sympathetic neural responses to Β-1 selective beta-blockade in untreated hypertension-related tachycardia.

Item

http://www.wikidata.org/entity/Q50140868

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@en

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@nl

type

Item

label

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@en

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@nl

prefLabel

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@en

Age-dependent sympathetic neur ...... ertension-related tachycardia.

@nl

P1476

Age-dependent sympathetic neur ...... pertension-related tachycardia

@en

P2093

Dagmara Hering

http://www.w3.org/2001/XMLSchema#string

Marzena Chrostowska

http://www.w3.org/2001/XMLSchema#string

Wiesława Kucharska

http://www.w3.org/2001/XMLSchema#string

P2860

Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis

β-Blockers in hypertension: studies and meta-analyses over the years.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Physiological aspects of primary hypertension.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging.

Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome.

Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive.

P304

158-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08037051.2018.1423543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Krzysztof Narkiewicz

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29308931

http://www.w3.org/2001/XMLSchema#string